img

Global Prostate Specific Antigen Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Prostate Specific Antigen Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Prostate Specific Antigen report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Prostate Specific Antigen market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Prostate Cancer and Metastatic Hormone Refractory Prostate Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Prostate Specific Antigen industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Prostate Specific Antigen key manufacturers include Advaxis, Inc., Aeterna Zentaris Inc., Bavarian Nordic A/S, Curevac AG, GenSpera, Inc., Inovio Pharmaceuticals, Inc. and OncBioMune Pharmaceuticals Inc., etc. Advaxis, Inc., Aeterna Zentaris Inc., Bavarian Nordic A/S are top 3 players and held % sales share in total in 2022.
Prostate Specific Antigen can be divided into G-115, INO-5150, ADXS-PSA and AEZS-120, etc. G-115 is the mainstream product in the market, accounting for % sales share globally in 2022.
Prostate Specific Antigen is widely used in various fields, such as Prostate Cancer, Metastatic Hormone Refractory Prostate Cancer and Others,, etc. Prostate Cancer provides greatest supports to the Prostate Specific Antigen industry development. In 2022, global % sales of Prostate Specific Antigen went into Prostate Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prostate Specific Antigen market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Advaxis, Inc.
Aeterna Zentaris Inc.
Bavarian Nordic A/S
Curevac AG
GenSpera, Inc.
Inovio Pharmaceuticals, Inc.
OncBioMune Pharmaceuticals Inc.
Segment by Type
G-115
INO-5150
ADXS-PSA
AEZS-120
Others

Segment by Application


Prostate Cancer
Metastatic Hormone Refractory Prostate Cancer
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Prostate Specific Antigen market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Prostate Specific Antigen, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Prostate Specific Antigen industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Prostate Specific Antigen in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Prostate Specific Antigen introduction, etc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Prostate Specific Antigen market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Prostate Specific Antigen Market Overview
1.1 Prostate Specific Antigen Product Overview
1.2 Prostate Specific Antigen Market Segment by Type
1.2.1 G-115
1.2.2 INO-5150
1.2.3 ADXS-PSA
1.2.4 AEZS-120
1.2.5 Others
1.3 Global Prostate Specific Antigen Market Size by Type
1.3.1 Global Prostate Specific Antigen Market Size Overview by Type (2018-2034)
1.3.2 Global Prostate Specific Antigen Historic Market Size Review by Type (2018-2024)
1.3.3 Global Prostate Specific Antigen Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Prostate Specific Antigen Sales Breakdown by Type (2018-2024)
1.4.2 Europe Prostate Specific Antigen Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Prostate Specific Antigen Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Prostate Specific Antigen Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Prostate Specific Antigen Sales Breakdown by Type (2018-2024)
2 Global Prostate Specific Antigen Market Competition by Company
2.1 Global Top Players by Prostate Specific Antigen Sales (2018-2024)
2.2 Global Top Players by Prostate Specific Antigen Revenue (2018-2024)
2.3 Global Top Players by Prostate Specific Antigen Price (2018-2024)
2.4 Global Top Manufacturers Prostate Specific Antigen Manufacturing Base Distribution, Sales Area, Product Type
2.5 Prostate Specific Antigen Market Competitive Situation and Trends
2.5.1 Prostate Specific Antigen Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Prostate Specific Antigen Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostate Specific Antigen as of 2022)
2.7 Date of Key Manufacturers Enter into Prostate Specific Antigen Market
2.8 Key Manufacturers Prostate Specific Antigen Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Prostate Specific Antigen Status and Outlook by Region
3.1 Global Prostate Specific Antigen Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Prostate Specific Antigen Historic Market Size by Region
3.2.1 Global Prostate Specific Antigen Sales in Volume by Region (2018-2024)
3.2.2 Global Prostate Specific Antigen Sales in Value by Region (2018-2024)
3.2.3 Global Prostate Specific Antigen Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Prostate Specific Antigen Forecasted Market Size by Region
3.3.1 Global Prostate Specific Antigen Sales in Volume by Region (2024-2034)
3.3.2 Global Prostate Specific Antigen Sales in Value by Region (2024-2034)
3.3.3 Global Prostate Specific Antigen Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Prostate Specific Antigen by Application
4.1 Prostate Specific Antigen Market Segment by Application
4.1.1 Prostate Cancer
4.1.2 Metastatic Hormone Refractory Prostate Cancer
4.1.3 Others
4.2 Global Prostate Specific Antigen Market Size by Application
4.2.1 Global Prostate Specific Antigen Market Size Overview by Application (2018-2034)
4.2.2 Global Prostate Specific Antigen Historic Market Size Review by Application (2018-2024)
4.2.3 Global Prostate Specific Antigen Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Prostate Specific Antigen Sales Breakdown by Application (2018-2024)
4.3.2 Europe Prostate Specific Antigen Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Prostate Specific Antigen Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Prostate Specific Antigen Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Prostate Specific Antigen Sales Breakdown by Application (2018-2024)
5 North America Prostate Specific Antigen by Country
5.1 North America Prostate Specific Antigen Historic Market Size by Country
5.1.1 North America Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Prostate Specific Antigen Sales in Volume by Country (2018-2024)
5.1.3 North America Prostate Specific Antigen Sales in Value by Country (2018-2024)
5.2 North America Prostate Specific Antigen Forecasted Market Size by Country
5.2.1 North America Prostate Specific Antigen Sales in Volume by Country (2024-2034)
5.2.2 North America Prostate Specific Antigen Sales in Value by Country (2024-2034)
6 Europe Prostate Specific Antigen by Country
6.1 Europe Prostate Specific Antigen Historic Market Size by Country
6.1.1 Europe Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Prostate Specific Antigen Sales in Volume by Country (2018-2024)
6.1.3 Europe Prostate Specific Antigen Sales in Value by Country (2018-2024)
6.2 Europe Prostate Specific Antigen Forecasted Market Size by Country
6.2.1 Europe Prostate Specific Antigen Sales in Volume by Country (2024-2034)
6.2.2 Europe Prostate Specific Antigen Sales in Value by Country (2024-2034)
7 Asia-Pacific Prostate Specific Antigen by Region
7.1 Asia-Pacific Prostate Specific Antigen Historic Market Size by Region
7.1.1 Asia-Pacific Prostate Specific Antigen Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Prostate Specific Antigen Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Prostate Specific Antigen Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Prostate Specific Antigen Forecasted Market Size by Region
7.2.1 Asia-Pacific Prostate Specific Antigen Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Prostate Specific Antigen Sales in Value by Region (2024-2034)
8 Latin America Prostate Specific Antigen by Country
8.1 Latin America Prostate Specific Antigen Historic Market Size by Country
8.1.1 Latin America Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Prostate Specific Antigen Sales in Volume by Country (2018-2024)
8.1.3 Latin America Prostate Specific Antigen Sales in Value by Country (2018-2024)
8.2 Latin America Prostate Specific Antigen Forecasted Market Size by Country
8.2.1 Latin America Prostate Specific Antigen Sales in Volume by Country (2024-2034)
8.2.2 Latin America Prostate Specific Antigen Sales in Value by Country (2024-2034)
9 Middle East and Africa Prostate Specific Antigen by Country
9.1 Middle East and Africa Prostate Specific Antigen Historic Market Size by Country
9.1.1 Middle East and Africa Prostate Specific Antigen Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Prostate Specific Antigen Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Prostate Specific Antigen Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Prostate Specific Antigen Forecasted Market Size by Country
9.2.1 Middle East and Africa Prostate Specific Antigen Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Prostate Specific Antigen Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Advaxis, Inc.
10.1.1 Advaxis, Inc. Company Information
10.1.2 Advaxis, Inc. Introduction and Business Overview
10.1.3 Advaxis, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Advaxis, Inc. Prostate Specific Antigen Products Offered
10.1.5 Advaxis, Inc. Recent Development
10.2 Aeterna Zentaris Inc.
10.2.1 Aeterna Zentaris Inc. Company Information
10.2.2 Aeterna Zentaris Inc. Introduction and Business Overview
10.2.3 Aeterna Zentaris Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Aeterna Zentaris Inc. Prostate Specific Antigen Products Offered
10.2.5 Aeterna Zentaris Inc. Recent Development
10.3 Bavarian Nordic A/S
10.3.1 Bavarian Nordic A/S Company Information
10.3.2 Bavarian Nordic A/S Introduction and Business Overview
10.3.3 Bavarian Nordic A/S Prostate Specific Antigen Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bavarian Nordic A/S Prostate Specific Antigen Products Offered
10.3.5 Bavarian Nordic A/S Recent Development
10.4 Curevac AG
10.4.1 Curevac AG Company Information
10.4.2 Curevac AG Introduction and Business Overview
10.4.3 Curevac AG Prostate Specific Antigen Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Curevac AG Prostate Specific Antigen Products Offered
10.4.5 Curevac AG Recent Development
10.5 GenSpera, Inc.
10.5.1 GenSpera, Inc. Company Information
10.5.2 GenSpera, Inc. Introduction and Business Overview
10.5.3 GenSpera, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2018-2024)
10.5.4 GenSpera, Inc. Prostate Specific Antigen Products Offered
10.5.5 GenSpera, Inc. Recent Development
10.6 Inovio Pharmaceuticals, Inc.
10.6.1 Inovio Pharmaceuticals, Inc. Company Information
10.6.2 Inovio Pharmaceuticals, Inc. Introduction and Business Overview
10.6.3 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Products Offered
10.6.5 Inovio Pharmaceuticals, Inc. Recent Development
10.7 OncBioMune Pharmaceuticals Inc.
10.7.1 OncBioMune Pharmaceuticals Inc. Company Information
10.7.2 OncBioMune Pharmaceuticals Inc. Introduction and Business Overview
10.7.3 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2018-2024)
10.7.4 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Products Offered
10.7.5 OncBioMune Pharmaceuticals Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Prostate Specific Antigen Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Prostate Specific Antigen Industrial Chain Analysis
11.4 Prostate Specific Antigen Market Dynamics
11.4.1 Prostate Specific Antigen Industry Trends
11.4.2 Prostate Specific Antigen Market Drivers
11.4.3 Prostate Specific Antigen Market Challenges
11.4.4 Prostate Specific Antigen Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Prostate Specific Antigen Distributors
12.3 Prostate Specific Antigen Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of G-115
Table 2. Major Company of INO-5150
Table 3. Major Company of ADXS-PSA
Table 4. Major Company of AEZS-120
Table 5. Major Company of Others
Table 6. Global Prostate Specific Antigen Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Prostate Specific Antigen Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Prostate Specific Antigen Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Prostate Specific Antigen Sales by Type (2018-2024) & (US& Million)
Table 10. Global Prostate Specific Antigen Market Share in Value by Type (2018-2024)
Table 11. Global Prostate Specific Antigen Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Prostate Specific Antigen Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Prostate Specific Antigen Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Prostate Specific Antigen Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Prostate Specific Antigen Sales Market Share in Value by Type (2024-2034)
Table 16. Global Prostate Specific Antigen Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Prostate Specific Antigen Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Prostate Specific Antigen Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Prostate Specific Antigen Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Prostate Specific Antigen Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Prostate Specific Antigen Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Prostate Specific Antigen Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Prostate Specific Antigen Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Prostate Specific Antigen Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Prostate Specific Antigen Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Prostate Specific Antigen Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Prostate Specific Antigen Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Prostate Specific Antigen Sales Share by Company (2018-2024)
Table 29. Global Prostate Specific Antigen Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Prostate Specific Antigen Revenue Share by Company (2018-2024)
Table 31. Global Market Prostate Specific Antigen Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Prostate Specific Antigen Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Prostate Specific Antigen Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostate Specific Antigen as of 2022)
Table 35. Date of Key Manufacturers Enter into Prostate Specific Antigen Market
Table 36. Key Manufacturers Prostate Specific Antigen Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Prostate Specific Antigen Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Prostate Specific Antigen Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Prostate Specific Antigen Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Prostate Specific Antigen Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Prostate Specific Antigen Sales Market Share in Value by Region (2018-2024)
Table 43. Global Prostate Specific Antigen Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Prostate Specific Antigen Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Prostate Specific Antigen Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Prostate Specific Antigen Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Prostate Specific Antigen Sales Market Share in Value by Region (2024-2034)
Table 48. Global Prostate Specific Antigen Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Prostate Specific Antigen Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Prostate Specific Antigen Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Prostate Specific Antigen Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Prostate Specific Antigen Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Prostate Specific Antigen Sales Market Share in Value by Application (2018-2024)
Table 54. Global Prostate Specific Antigen Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Prostate Specific Antigen Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Prostate Specific Antigen Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Prostate Specific Antigen Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Prostate Specific Antigen Sales Market Share in Value by Application (2024-2034)
Table 59. Global Prostate Specific Antigen Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Prostate Specific Antigen Sales by Application (2018-2024) (K Pcs)
Table 61. North America Prostate Specific Antigen Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Prostate Specific Antigen Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Prostate Specific Antigen Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Prostate Specific Antigen Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Prostate Specific Antigen Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Prostate Specific Antigen Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Prostate Specific Antigen Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Prostate Specific Antigen Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Prostate Specific Antigen Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Prostate Specific Antigen Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Prostate Specific Antigen Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Prostate Specific Antigen Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Prostate Specific Antigen Sales Market Share in Value by Country (2018-2024)
Table 74. North America Prostate Specific Antigen Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Prostate Specific Antigen Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Prostate Specific Antigen Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Prostate Specific Antigen Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Prostate Specific Antigen Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Prostate Specific Antigen Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Prostate Specific Antigen Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Prostate Specific Antigen Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Prostate Specific Antigen Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Prostate Specific Antigen Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Prostate Specific Antigen Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Prostate Specific Antigen Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Prostate Specific Antigen Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Prostate Specific Antigen Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Prostate Specific Antigen Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Prostate Specific Antigen Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Prostate Specific Antigen Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Prostate Specific Antigen Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Prostate Specific Antigen Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Prostate Specific Antigen Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Prostate Specific Antigen Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Prostate Specific Antigen Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Prostate Specific Antigen Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Prostate Specific Antigen Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Prostate Specific Antigen Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Prostate Specific Antigen Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Prostate Specific Antigen Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Prostate Specific Antigen Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Prostate Specific Antigen Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Prostate Specific Antigen Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Prostate Specific Antigen Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Prostate Specific Antigen Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Prostate Specific Antigen Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Prostate Specific Antigen Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Prostate Specific Antigen Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Prostate Specific Antigen Sales Market Share in Value by Country (2024-2034)
Table 110. Advaxis, Inc. Company Information
Table 111. Advaxis, Inc. Introduction and Business Overview
Table 112. Advaxis, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Advaxis, Inc. Prostate Specific Antigen Product
Table 114. Advaxis, Inc. Recent Development
Table 115. Aeterna Zentaris Inc. Company Information
Table 116. Aeterna Zentaris Inc. Introduction and Business Overview
Table 117. Aeterna Zentaris Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Aeterna Zentaris Inc. Prostate Specific Antigen Product
Table 119. Aeterna Zentaris Inc. Recent Development
Table 120. Bavarian Nordic A/S Company Information
Table 121. Bavarian Nordic A/S Introduction and Business Overview
Table 122. Bavarian Nordic A/S Prostate Specific Antigen Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Bavarian Nordic A/S Prostate Specific Antigen Product
Table 124. Bavarian Nordic A/S Recent Development
Table 125. Curevac AG Company Information
Table 126. Curevac AG Introduction and Business Overview
Table 127. Curevac AG Prostate Specific Antigen Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Curevac AG Prostate Specific Antigen Product
Table 129. Curevac AG Recent Development
Table 130. GenSpera, Inc. Company Information
Table 131. GenSpera, Inc. Introduction and Business Overview
Table 132. GenSpera, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. GenSpera, Inc. Prostate Specific Antigen Product
Table 134. GenSpera, Inc. Recent Development
Table 135. Inovio Pharmaceuticals, Inc. Company Information
Table 136. Inovio Pharmaceuticals, Inc. Introduction and Business Overview
Table 137. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Product
Table 139. Inovio Pharmaceuticals, Inc. Recent Development
Table 140. OncBioMune Pharmaceuticals Inc. Company Information
Table 141. OncBioMune Pharmaceuticals Inc. Introduction and Business Overview
Table 142. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Product
Table 144. OncBioMune Pharmaceuticals Inc. Recent Development
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Prostate Specific Antigen Market Trends
Table 148. Prostate Specific Antigen Market Drivers
Table 149. Prostate Specific Antigen Market Challenges
Table 150. Prostate Specific Antigen Market Restraints
Table 151. Prostate Specific Antigen Distributors List
Table 152. Prostate Specific Antigen Downstream Customers
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Specific Antigen Product Picture
Figure 2. Global Prostate Specific Antigen Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Prostate Specific Antigen Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Prostate Specific Antigen Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of G-115
Figure 6. Global G-115 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of INO-5150
Figure 8. Global INO-5150 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of ADXS-PSA
Figure 10. Global ADXS-PSA Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of AEZS-120
Figure 12. Global AEZS-120 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Prostate Specific Antigen Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Prostate Specific Antigen Sales Market Share by Type in 2022 & 2034
Figure 17. North America Prostate Specific Antigen Sales Market Share in Volume by Type in 2022
Figure 18. North America Prostate Specific Antigen Sales Market Share in Value by Type in 2022
Figure 19. Europe Prostate Specific Antigen Sales Market Share in Volume by Type in 2022
Figure 20. Europe Prostate Specific Antigen Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Prostate Specific Antigen Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Prostate Specific Antigen Sales Market Share in Value by Type in 2022
Figure 23. Latin America Prostate Specific Antigen Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Prostate Specific Antigen Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Prostate Specific Antigen Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Prostate Specific Antigen Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Prostate Specific Antigen Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Prostate Specific Antigen Revenue in 2022
Figure 29. Prostate Specific Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Prostate Cancer
Figure 31. Global Prostate Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Metastatic Hormone Refractory Prostate Cancer
Figure 33. Global Metastatic Hormone Refractory Prostate Cancer Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Prostate Specific Antigen Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Prostate Specific Antigen Sales Market Share by Application in 2022 & 2034
Figure 38. North America Prostate Specific Antigen Sales Market Share in Volume by Application in 2022
Figure 39. North America Prostate Specific Antigen Sales Market Share in Value by Application in 2022
Figure 40. Europe Prostate Specific Antigen Sales Market Share in Volume by Application in 2022
Figure 41. Europe Prostate Specific Antigen Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Prostate Specific Antigen Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Prostate Specific Antigen Sales Market Share in Value by Application in 2022
Figure 44. Latin America Prostate Specific Antigen Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Prostate Specific Antigen Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Prostate Specific Antigen Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Prostate Specific Antigen Manufacturing Cost Structure
Figure 49. Prostate Specific Antigen Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed